Skip to main content
SpringerLink
Log in

Growth Control of Melanoma Cells and Melanocytes by Cytokines

  • Conference paper
Skin Cancer: Basic Science, Clinical Research and Treatment

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 139))

Abstract

Aberrant proliferation of tumor cells characterizes cancer growth. Investigations of cellular growth control mechanisms have contributed to our understanding of carcinogenesis and to the identification of compounds with specific antitumor activity. Many cytokines have been found to act on melanoma tumors, either produced by the tumor cells themselves or by infiltrating host cells. Purified cytokines allowed direct comparison of the growth response between normal human melanocytes and malignant melanoma cells. The present paper summarizes results of a series of our own experiments not yet published and data from a review of the recent literature. Proliferation of normal human melanocytes is enhanced by several cytokines, including basic fibroblast growth factor (bFGF), melanoma growth stimulatory activity (MGSA), hepatocyte growth factor (HGF), and mast cell growth factor (MGF). Melanoma cells are additionally stimulated by epidermal growth factor (EGF)/transforming growth factor alpha (TGF-α) and nerve growth factor (NGF). Tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β 1), and interleukin (IL)-6 are all potent inhibitors of melanocyte growth, but they are less effective on melanoma cells or even stimulate their growth. Interferon (IFN)-α and IFN-γ inhibited proliferation of melanoma cells but not of melanocytes, whereas IFN-β showed antiproliferative effects in both cell types. These findings suggest an alteration in growth control mechanisms during melanocyte transformation and possibly play a role in melanoma pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albino P, Davis BM, Nanus DM (1991) Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 51:4815–4820

    PubMed  CAS  Google Scholar 

  • Arita Y, O’Driscoll KR, Weinstein BI (1992) Growth of human melanocyte cultures supported by 12–0-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res 52:4514–4521

    PubMed  CAS  Google Scholar 

  • Becker D, Meier CB, Herlyn M (1989) Proliferation of human malignant melanomas is inhibited by antisense oligonucleotides targeted against basic fibroblast growth factor. EMBO J 8:3685–3691

    PubMed  CAS  Google Scholar 

  • Becker D, Lee PL, Rodeck U, Herlyn M (1992) Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7:2303–2313

    PubMed  CAS  Google Scholar 

  • Bordoni R, Fine R, Murray D, Richmond A (1990) Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J Cell Biochem 44:207–219

    Article  PubMed  CAS  Google Scholar 

  • Carpenter G, Cohen S (1979) Epidermal growth factor. Annu Rev Biochem 48: 193–216

    Article  PubMed  CAS  Google Scholar 

  • Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R, Massague J (1987) The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409–415

    Article  PubMed  CAS  Google Scholar 

  • Chenevix-Trench G, Martin NG, Ellem KAO (1990) Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53. Oncogene 5:1187–1193

    PubMed  CAS  Google Scholar 

  • Dotto GP, Moelmann G, Ghosh S, Edwards M, Halaban R (1989) Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous enviroment. J Cell Biol 109:3115–3128

    Article  PubMed  CAS  Google Scholar 

  • Eisinger M, Marco O (1982) Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 79:2018–2022

    Article  PubMed  CAS  Google Scholar 

  • Fabricant RN, DeLarco JE, Todaro GJ (1977) Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci USA 74:565–569

    Article  PubMed  CAS  Google Scholar 

  • Fisher PB, Miranda AF, Babiss LE (1986) Measurement of the effect of interferons on cellular differentiation in murine and human melanoma cells. Methods Enzymol 119:611–618

    Article  PubMed  CAS  Google Scholar 

  • Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y, Halaban R (1992) c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3:197–209

    PubMed  CAS  Google Scholar 

  • Garbe C, Krasagakis K, Zouboulis CC, Schröder K, Krüger S, Stadler R, Orfanos CE (1990) Antitumor activities of interferon alpha, beta and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis and immunophenotype. J Invest Dermatol 95:23IS–237S

    Article  Google Scholar 

  • Garbe C, Kreuser ED, Zouboulis CC, Stadler R, Orfanos CE (1992) Combined treatment of metastatic melanoma with interferons and cytotoxic drugs. Semin Oncol 19 [Suppl 4]:63–69

    PubMed  CAS  Google Scholar 

  • Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A (1988a) bFGF as an autocrine growth factor for human melanomas. Oncogene Res 3:177–186

    PubMed  CAS  Google Scholar 

  • Halaban R, Langdon R, Birchall N, Cuono C, Baird A, Scott G, Moellmann G, McGuire J (1988b) Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 107:1611–1619

    Article  PubMed  CAS  Google Scholar 

  • Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W et al (1992a) Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195–2206

    PubMed  CAS  Google Scholar 

  • Halaban R, Fan B, Ahn J, Funasaka Y, Gitay Goren H, Neufeld G (1992b) Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother 12:154–161

    Article  PubMed  CAS  Google Scholar 

  • Herlyn M, Thurin J, Balaban G, Benicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, Koprowski H (1985) Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45:5670–5676

    PubMed  CAS  Google Scholar 

  • Herlyn M, Kath R, Williams N, Valyi-Nagy I, Rodeck U (1990) Growth-regulatory factors for normal, premalignant and malignant human cells in vitro. Adv Cancer Res 54:213–234

    Article  PubMed  CAS  Google Scholar 

  • Kim MK, Warren TC, Kimball ES (1985) Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. J Biol Chem 260:9237–9243

    PubMed  CAS  Google Scholar 

  • Krasagakis K, Garbe C, Krüger S, Orfanos CE (1991) Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not -alpha or –gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol 97:364–372

    Article  PubMed  CAS  Google Scholar 

  • Krasagakis K, Garbe C, Krüger-Krasagakes S, Orfanos CE (1993) 12–0 tetra-decanoylphorbol-13-acetate not only modulates proliferation rates but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitro. J Invest Dermatol 100:653–659

    Article  PubMed  CAS  Google Scholar 

  • Lawson DH, Thomas HG, Roy RGB, Gordon DS, Chawla RK, Nixon DW, Richmond A (1987) Preparation of a monoclonal antibody to melanoma growth stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells. J Cell Biochem 34:169–185

    Article  PubMed  CAS  Google Scholar 

  • Lu C, Kerbel RS (1993) Interleukin 6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 120:1281–1288

    Article  PubMed  CAS  Google Scholar 

  • Lu C, Vickers MF, Kerbel RS (1992) Interleukin 6: a fibroblast derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 89:9215–9219

    Article  PubMed  CAS  Google Scholar 

  • Mather JP, Sato GH (1979) The growth of mouse melanoma cells in hormone-supplemented, serum-free medium. Exp Cell Res 120:191–200

    Article  PubMed  CAS  Google Scholar 

  • Mooradian DL, Purchio AF, Furcht LT (1990) Differential effects of transforming growth factor β 1 on the growth of poorly and highly metastatic murine melanoma cells. Cancer Res 50:273–277

    PubMed  CAS  Google Scholar 

  • Mortarini R, Belli F, Parmiani G, Anichini A (1990) Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations. Int J Cancer 45:334–341

    Article  PubMed  CAS  Google Scholar 

  • Nakai S, Mizuno K, Kaneta M, Hirai Y (1988) A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem Biophys Res Commun 154:1189–1196

    Article  PubMed  CAS  Google Scholar 

  • Peacocke M, Yaar M, Mansur CP, Chao MV, Gilchrest BA (1988) Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci USA 85:5282–5286

    Article  PubMed  CAS  Google Scholar 

  • Richmond A, Thomas HG (1988) Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185–198

    Article  PubMed  CAS  Google Scholar 

  • Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke R, Derynck R (1988) Molecular characterisation and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin. EMBO J 7:2025–2033

    PubMed  CAS  Google Scholar 

  • Rodeck U, Herlyn, M, Menssen HD, Furlanetto RW, Koprowski H (1987) Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer 40:687–690

    Article  PubMed  CAS  Google Scholar 

  • Rodeck U, Melber K, Kath R, Menssen H-D, Varello M, Atkinson B, Herlyn M (1991) Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97:20–26

    Article  PubMed  CAS  Google Scholar 

  • Sauvaigo S, Fretts RE, Riopelle RJ, Lagard AE (1986) Autonomous proliferation of MeWo human melanoma cell lines in serum-free medium: secretion of growth-stimulating activities. Int J Cancer 37:123–132

    Article  PubMed  CAS  Google Scholar 

  • Schadendorf D, Möller A, Algermissen B, Worm M, Sticherling M, Czarniecki BM (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151:2667–2675

    PubMed  CAS  Google Scholar 

  • Sun WH, Kreisle RA, Phillips AW, Ershler WB (1992) In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res 52:5412–5415

    PubMed  CAS  Google Scholar 

  • Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ (1991) Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 96:180–185

    Article  PubMed  CAS  Google Scholar 

  • Todaro GJ (1988) Oncogenes and growth factors. In: Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Springer, Berlin Heidelberg New York, pp 11–25

    Google Scholar 

  • Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC (1992) Nonhematopoietic tumor cells express stem cell factor and display c-kit receptors. Blood 80:374–381

    PubMed  CAS  Google Scholar 

  • Tyring SK, Klimpel G, Brysk M (1984) Eradication of cultured human melanoma cells by immune interferon and leukocytes. J Natl Cancer Inst 73:1067–1073

    PubMed  CAS  Google Scholar 

  • Wadler S, Schwartz EL (1990) Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50:3473–3486

    PubMed  CAS  Google Scholar 

  • Zouboulis CC, Garbe C, Krüger S, Orfanos CE (1990a) Interferons and melanoma: comparison of the cytostatic and cytotoxic effects of natural and recombinant interferons, tumor necrosis factor-alpha and their combinations on human melanoma cells in vitro. Skin Cancer 5:137–145

    Google Scholar 

  • Zouboulis CC, Schröder K, Garbe C, Krasagakis K, Krüger S, Orfanos CE (1990b) Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-alpha on sensitive human melanoma cells in vitro may result in selection of cells with enhanced markers of malignancy. J Invest Dermatol 95:223S–230S

    Article  PubMed  CAS  Google Scholar 

  • Zouboulis CC, Garbe C, Krasagakis K, Krüger S, Orfanos CE (1991) A fluorometric rapid microassay to identify antiproliferative compounds for human melanoma cells in vitro. Melanoma Res 1:91–95

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University Medical Center Steglitz, The Free University of Berlin, Hindenburgdamm 30, 12200, Berlin, Germany

    K. Krasagakis, C. Garbe, Ch. C. Zouboulis & C. E. Orfanos

Authors
  1. K. Krasagakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ch. C. Zouboulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Department of Dermatology Medical Centre Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, 12200, Berlin, Germany

    Claus Garbe , Stefan Schmitz  & Constantin E. Orfanos ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Krasagakis, K., Garbe, C., Zouboulis, C.C., Orfanos, C.E. (1995). Growth Control of Melanoma Cells and Melanocytes by Cytokines. In: Garbe, C., Schmitz, S., Orfanos, C.E. (eds) Skin Cancer: Basic Science, Clinical Research and Treatment. Recent Results in Cancer Research, vol 139. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78771-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78771-3_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78773-7

  • Online ISBN: 978-3-642-78771-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation